Paragangliomas
- 1 August 2006
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1073 (1), 21-29
- https://doi.org/10.1196/annals.1353.002
Abstract
Paragangliomas are rare tumors that arise from extra-adrenal paraganglia. The effective diagnosis and management of the paraganglioma patient involves the close collaboration of endocrinologists, endocrine surgeons, anesthesiologists, geneticists, laboratory specialists, radiologists, oncologists, and pathologists. Paragangliomas are diagnosed in the following clinical settings: signs and symptoms related to catecholamine hypersecretion, mass effect symptoms (e.g., with head and neck paragangliomas), incidental finding on imaging, or family screening for hereditary paraganglioma. Paragangliomas that hypersecrete catecholamines may cause signs and symptoms identical to those in patients with hyperfunctioning adrenal pheochromocytoma. When a catecholamine-secreting tumor is suspected in a patient because of paroxysmal symptoms, biochemical documentation of catecholamine and fractionated metanephrine hypersecretion should precede any form of imaging study. Catecholamine-secreting paragangliomas are found where chromaffin tissue is located (e.g., along the para-aortic sympathetic chain, or within the organs of Zuckerkandl at the origin of the inferior mesenteric artery, the wall of the urinary bladder, and the sympathetic chain in the neck or mediastinum). As many as 50% of paragangliomas are hereditary and may be associated with familial paraganglioma, neurofibromatosis Type 1, von Hippel-Lindau disease, the Carney triad, and, rarely, with multiple endocrine neoplasia Type 2. Genetic testing should be considered in all patients with paraganglioma. The treatment of choice for paraganglioma is surgical resection; most tumors are benign and can be excised totally. Following surgical cure, annual biochemical testing assesses for metastatic disease, tumor recurrence or delayed appearance of multiple primary tumors.Keywords
This publication has 16 references indexed in Scilit:
- Clinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma SyndromesJournal of Clinical Endocrinology & Metabolism, 2006
- Predictors and Prevalence of Paraganglioma Syndrome Associated With Mutations of the SDHC GeneJama-Journal Of The American Medical Association, 2005
- Distinct Clinical Features of Paraganglioma Syndromes Associated With SDHB and SDHD Gene MutationsPublished by American Medical Association (AMA) ,2004
- The Laboratory Diagnosis of Adrenal Pheochromocytoma: The Mayo Clinic ExperienceJournal of Clinical Endocrinology & Metabolism, 2003
- Biochemical Diagnosis of PheochromocytomaJama-Journal Of The American Medical Association, 2002
- Benign Paragangliomas: Clinical Presentation and Treatment Outcomes in 236 PatientsJournal of Clinical Endocrinology & Metabolism, 2001
- Perianesthetic Risks and Outcomes of Pheochromocytoma and Paraganglioma ResectionAnesthesia & Analgesia, 2000
- Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary ParagangliomaScience, 2000
- Gastric Stromal Sarcoma, Pulmonary Chondroma, and Extra-adrenal Paraganglioma (Carney Triad): Natural History, Adrenocortical Component, and Possible Familial OccurrenceMayo Clinic Proceedings, 1999
- Clinical Spectrum and Outcome of Functional Extraadrenal ParagangliomaWorld Journal of Surgery, 1996